Pharmacological treatments for obesity.
Carol McLoughlin looks at the advantages and drawbacks of using drugs to treat obesity and describes new areas of research that may offer new solutions to tackling this rapidly growing health and medical problem.
McLoughlin
Carol
C
D019440:Anti-Obesity Agents / Q000627:therapeutic use*; D001067:Appetite Depressants / Q000627:therapeutic use; D003503:Cyclobutanes / Q000627:therapeutic use; D006801:Humans; D007783:Lactones / Q000627:therapeutic use; D020738:Leptin / Q000378:metabolism; D009765:Obesity / Q000188:drug therapy* / Q000378:metabolism; D000077403:Orlistat
D019440:Anti-Obesity Agents; D001067:Appetite Depressants; D003503:Cyclobutanes; D007783:Lactones; D020738:Leptin; D000077403:Orlistat; C058254:sibutramine